blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2855509

EP2855509 - NON-NATURAL CONSENSUS ALBUMIN BINDING DOMAINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.03.2019
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  30.03.2018
FormerGrant of patent is intended
Status updated on  23.03.2018
FormerExamination is in progress
Status updated on  15.12.2017
FormerGrant of patent is intended
Status updated on  02.08.2017
FormerExamination is in progress
Status updated on  24.02.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): CY, MK		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Janssen Biotech, Inc.
800/850 Ridgeview Drive
Horsham, PA 19044 / US
[2015/15]
Inventor(s)01 / JACOBS, Steven
1400 McKean Road
Spring House, Pennsylvania 19477 / US
 [2015/15]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2015/15]
Application number, filing date13793564.923.05.2013
[2018/18]
WO2013US42429
Priority number, dateUS201261651642P25.05.2012         Original published format: US 201261651642 P
US201361776918P12.03.2013         Original published format: US 201361776918 P
[2015/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2013177398
Date:28.11.2013
Language:EN
[2013/48]
Type: A2 Application without search report 
No.:EP2855509
Date:08.04.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 28.11.2013 takes the place of the publication of the European patent application.
[2015/15]
Type: B1 Patent specification 
No.:EP2855509
Date:02.05.2018
Language:EN
[2018/18]
Search report(s)International search report - published on:US27.03.2014
(Supplementary) European search report - dispatched on:EP16.12.2015
ClassificationIPC:C07K14/00, C07K14/76, C07K17/00
[2015/15]
CPC:
C07K14/31 (EP,CN,IL,US); C07K14/315 (IL,US); C07K14/001 (IL,KR,US);
A61P43/00 (EP); C07K14/47 (EP,CN,IL,US); C07K14/76 (KR);
C07K19/00 (KR); A61K38/00 (CN); C07K2319/00 (CN);
C07K2319/01 (IL,US); C07K2319/31 (IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/15]
Extension statesBA23.12.2014
ME23.12.2014
TitleGerman:NICHTNATÜRLICHE ALBUMINBINDENDE DOMÄNEN[2015/15]
English:NON-NATURAL CONSENSUS ALBUMIN BINDING DOMAINS[2015/15]
French:DOMAINES CONSENSUS NON ENDOGÈNES DE LIAISON À L'ALBUMINE[2015/15]
Entry into regional phase23.12.2014National basic fee paid 
23.12.2014Search fee paid 
23.12.2014Designation fee(s) paid 
23.12.2014Examination fee paid 
Examination procedure23.12.2014Examination requested  [2015/15]
21.07.2016Amendment by applicant (claims and/or description)
23.02.2017Despatch of a communication from the examining division (Time limit: M04)
27.06.2017Reply to a communication from the examining division
03.08.2017Communication of intention to grant the patent
13.12.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
13.12.2017Fee for grant paid
13.12.2017Fee for publishing/printing paid
23.03.2018Information about intention to grant a patent
23.03.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18170257.2   Application refused  : 08.10.2018
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.02.2017
Opposition(s)05.02.2019No opposition filed within time limit [2019/15]
Fees paidRenewal fee
12.05.2015Renewal fee patent year 03
10.05.2016Renewal fee patent year 04
10.05.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.05.2013
AL02.05.2018
CY02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
MK02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
TR02.05.2018
LU23.05.2018
MT23.05.2018
BG02.08.2018
GR03.08.2018
[2020/31]
Former [2020/30]HU23.05.2013
AL02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
TR02.05.2018
LU23.05.2018
MT23.05.2018
BG02.08.2018
GR03.08.2018
Former [2020/16]AL02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
TR02.05.2018
LU23.05.2018
MT23.05.2018
BG02.08.2018
GR03.08.2018
Former [2020/08]AL02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
LU23.05.2018
MT23.05.2018
BG02.08.2018
GR03.08.2018
Former [2019/51]AL02.05.2018
CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
LU23.05.2018
BG02.08.2018
GR03.08.2018
Former [2019/26]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SI02.05.2018
SK02.05.2018
SM02.05.2018
LU23.05.2018
BG02.08.2018
GR03.08.2018
Former [2019/17]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SK02.05.2018
SM02.05.2018
LU23.05.2018
BG02.08.2018
GR03.08.2018
Former [2019/15]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
MC02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
GR03.08.2018
Former [2019/11]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SK02.05.2018
SM02.05.2018
BG02.08.2018
GR03.08.2018
Former [2019/10]CZ02.05.2018
EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
PL02.05.2018
RO02.05.2018
RS02.05.2018
SK02.05.2018
BG02.08.2018
GR03.08.2018
Former [2019/09]EE02.05.2018
HR02.05.2018
LT02.05.2018
LV02.05.2018
RS02.05.2018
BG02.08.2018
GR03.08.2018
Former [2018/52]HR02.05.2018
LT02.05.2018
LV02.05.2018
RS02.05.2018
BG02.08.2018
GR03.08.2018
Former [2018/51]HR02.05.2018
LT02.05.2018
LV02.05.2018
RS02.05.2018
BG02.08.2018
Former [2018/50]HR02.05.2018
LT02.05.2018
BG02.08.2018
Former [2018/47]LT02.05.2018
Documents cited:Search[I]WO2010141329  (MEDIMMUNE LLC [US], et al) [I] 1-12 * page 9, line 19 - page 17; claims 1-21,27-30; sequence 2 *;
 [E]EP2922566  (JANSSEN BIOTECH INC [US]) [E] 1,7-15 * figure 1; sequence 117 *;
 [I]  - A. JONSSON ET AL, "Engineering of a femtomolar affinity binding protein to human serum albumin", PROTEIN ENGINEERING DESIGN AND SELECTION, (20080101), vol. 21, no. 8, doi:10.1093/protein/gzn028, ISSN 1741-0126, pages 515 - 527, XP055047773 [I] 1-12 * abstract *

DOI:   http://dx.doi.org/10.1093/protein/gzn028
 [A]  - JOHANSSON M U ET AL, "Solution structure of the albumin-binding GA module: a versatile bacterial protein domain", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, (19970314), vol. 266, no. 5, doi:10.1006/JMBI.1996.0856, ISSN 0022-2836, pages 859 - 865, XP004464325 [A] 1-15 * abstract * * page 861, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1006/jmbi.1996.0856
 [A]  - ROLAND E KONTERMANN, "Strategies for extended serum half-life of protein therapeutics", CURRENT OPINION IN BIOTECHNOLOGY, vol. 22, no. 6, doi:10.1016/J.COPBIO.2011.06.012, ISSN 0958-1669, (20111201), pages 868 - 876, (20110729), XP028397475 [A] 1-15

DOI:   http://dx.doi.org/10.1016/j.copbio.2011.06.012
 [T]  - JACOBS STEVEN A ET AL, "Fusion to a highly stable consensus albumin binding domain allows for tunable pharmacokinetics.", PROTEIN ENGINEERING, DESIGN & SELECTION : PEDS OCT 2015, (201510), vol. 28, no. 10, ISSN 1741-0134, pages 385 - 393, XP002751271 [T] * the whole document *

DOI:   http://dx.doi.org/10.1093/protein/gzv040
International search[A]US6162903  (TROWERN ANGUS R [GB], et al);
 [A]US2012100165  (ARAKAWA TAKESHI [JP], et al);
 [A]  - LEJON, S ET AL., "Structural Basis For The Binding Of Naproxen To Human Serum Albumin In The Presence Of Fatty Acids And The GA Module.", ACTA CRSTALLOGRAPHICA SECTION F: STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS., (20080201), vol. 64, no. 2, pages 64 - 69, XP055076182

DOI:   http://dx.doi.org/10.1107/S174430910706770X
by applicantUS6267964
 WO2010141329
    - KONTERMANN, Curr Opin Biotechnol, (20110000), vol. 22, pages 868 - 76
    - GABERC-POREKAR et al., Curr Opin Drug Discov Devel, (20080000), vol. 11, pages 242 - 250
    - KUO et al., J Clin Immunol, (20100000), vol. 30, pages 777 - 789
    - COPPIETERS et al., Arthritis Rheum, (20060000), vol. 54, pages 1856 - 1866
    - TIJINK et al., Mol Cancer Ther, (20080000), vol. 7, pages 2288 - 2297
    - HOLT et al., Protein Eng Des Sel, (20080000), vol. 21, pages 283 - 288
    - WALKER et al., Protein Eng Des Sel, (20100000), vol. 23, pages 271 - 278
    - CRAMER et al., FEBS Lett, (20070000), vol. 581, pages 3178 - 3182
    - LEJON et al., Acta Crystallogr Sect F Struct Biol Cryst Commun, (20080000), vol. 64, pages 64 - 69
    - JOHANSSON et al., FEBS Lett, (19950000), vol. 374, pages 257 - 261
    - JOHANSSON et al., J Mol Biol, (19970000), vol. 266, pages 859 - 865
    - JOHANSSON et al., J Biol Chem, (20020000), vol. 277, pages 8114 - 8120
    - JONSSON et al., Protein Eng Des Sel, (20080000), vol. 21, pages 515 - 527
    - MAKRIDES et al., J Pharmacol Exp Ther, (19960000), vol. 277, pages 534 - 542
    - STORK et al., Protein Eng Des Sel, (20070000), vol. 20, pages 569 - 576
    - NYGREN et al., Vaccines, (19910000), vol. 91, pages 363 - 368
    - STAHL et al., J Immunol Methods, (19890000), vol. 124, pages 43 - 52
    - ANDERSEN et al., J Biol Chem, (20110000), vol. 286, pages 5234 - 5241
    - GOETSCH et al., Clin Diagn Lab Immunol, (20030000), vol. 10, pages 125 - 132
    - LIBON et al., Vaccine, (19990000), vol. 17, pages 406 - 414
    - HOPP et al., Protein Eng Des Sel, (20100000), vol. 23, pages 827 - 834
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.